UTHR
NASDAQStockUnited Therapeutics Corporation
$535.60-9.14 (-1.68%)
52-Week Range
$274.70
$535.81
Key Stats
Market Cap
23.5B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Volume
377.4K
Avg Volume
605.0K
Performance
1M
+11.97%
3M
+6.50%
6M
+32.18%
YTD
+7.27%
1Y
+74.47%
3Y
+141.47%
5Y
+224.69%
Price Chart
ETF Exposure
UTHR is held by 241 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.04% |
| IWV | iShares Russell 3000 ETF | 0.04% |
| SCHB | Schwab U.S. Broad Market ETF | 0.04% |
| DFUS | Dimensional - US Equity Market ETF | 0.03% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.03% |
| FSMO | Fidelity Small-Mid Cap Opportunities ETF | 0.03% |
| FNDX | Schwab Fundamental U.S. Large Company Index ETF | 0.03% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.03% |
| TOK | iShares MSCI Kokusai ETF | 0.03% |
| VONE | Vanguard Russell 1000 ETF | 0.03% |
| KOKU | Xtrackers MSCI Kokusai Equity ETF | 0.03% |
| VTHR | Vanguard Russell 3000 ETF | 0.03% |
| VTI | Vanguard Total Stock Market ETF | 0.03% |
| FNDB | Schwab Fundamental U.S. Broad Market Index ETF | 0.03% |
| IALT | iShares Systematic Alternatives Active ETF | 0.03% |
| URTH | iShares MSCI World ETF | 0.03% |
| ACWI | iShares MSCI ACWI ETF | 0.03% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.02% |
| VT | Vanguard Total World Stock ETF | 0.02% |
| WLDU.L | Amundi MSCI World Swap II UCITS ETF USD Hedged Dist | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| NTSX | WisdomTree U.S. Efficient Core Fund | 0.01% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.01% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.01% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.01% |
| INRO | iShares U.S. Industry Rotation Active ETF | 0.01% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.01% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| XCHG | Alliance Bernstein - AB US Equity ETF | 0.00% |
| CHEP | AGFiQ U.S. Market Neutral Value Fund | 0.00% |
| FTLS | First Trust Long/Short Equity ETF | 0.00% |
PreviousPage 5 of 5
About UTHR ETF Exposure
United Therapeutics Corporation (UTHR) is held by 241 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 23.5B, UTHR is a widely held institutional stock. The stock currently trades at $535.60. Investors can gain exposure to UTHR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold UTHR, sorted by portfolio weight.